P/B
3,8
Pro-Dex
Pro-Dex Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers (OEMs) to various countries. Its product portfolio includes autoclavable, battery-powered, electric, and multi-function surgical drivers and shavers used mainly in orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, regulatory consulting services, and manufactures rotary air motors utilized in various industries. Operating out of ISO-certified facilities in California, Pro-Dex serves hospitals, medical labs, and high-tech manufacturers, generating revenue through sales of surgical instruments and related services.
Pro-Dex Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers (OEMs) to various countries. Its product portfolio includes autoclavable, battery-powered, electric, and multi-function surgical drivers and shavers used mainly in orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, regulatory consulting services, and manufactures rotary air motors utilized in various industries. Operating out of ISO-certified facilities in California, Pro-Dex serves hospitals, medical labs, and high-tech manufacturers, generating revenue through sales of surgical instruments and related services.
$186.1M
Market Cap • 10/30/2026
1994
(32 years)
Founded
1986
(40 years ago)
IPO
NASDAQ
Listing Exchange
United States
Country
Valuation
P/S
2,3
P/EBITDA
12,5
P/OCF
16,3
P/FCF
17,4
P/E
15,9
BVPS
15,4
EPS
3,7
Market Cap
Market Cap
186,1M
EV
191,7M
EV/Revenue
2,4
EV/EBITDA
12,9
EV/EBIT
14,3
Payout
Dividend Per Share
0
Dividend Yield
0%
Buyback Yield
2,6%
Total Yield
2,6%
Payout
0%
Retained Earnings
49,3M
Profitability
Gross Margin
32,5%
EBITDA Margin
18,7%
EBIT Margin
16,8%
Net Margin
26,1%
D&A/EBITDA
0%
R&D/Revenue
4,8%
Capex/Revenue
0,9%
Capex/D&A
49,2%
Capex/OCF
6,4%
SBC/OCF
5,8%
% PPE
17,4%
% Goodwill
8,5%
ROE
45,6%
ROIC
26,9%
Growth
CAGR Revenue 5Y
15,1%
CAGR Op. Income 5Y
25,6%
CAGR Net Income 5Y
30,4%
CAGR EPS 5Y
20,1%
CAGR OCF 5Y
49,9%
Leverage
N.D./EBITDA
0,4
Debt/Equity
0%
Current Ratio
4,2
Quick Ratio
2,4
Interest Coverage
1536,4%
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!